Available online on 15.10.2025 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

Copyright  © 2025 The   Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access Full Text Article                                                                                 Review Article

Therapeutic Potential of Ustukhuddus (Lavandula stoechas L.): The ‘Broom of the Brain’ in Unani Medicine and Neuropharmacology

Jahan Najeeb *1Parwej Ahmad 2, Saima Bano 2, Nasreen Jahan 3, KMY Amin 4

1* Professor and PhD Research Scholar, Dept. of Ilmul Advia (Pharmacology), National Institute of Unani Medicine, Bangalore, India.

P.G scholar, Dept of Ilmul Advia (Pharmacology), National Institute of Unani Medicine, Bangalore, Karnataka, India.

Professor, Department of Ilmul Advia, National Institute of Unani Medicine, Bangalore, India

Professor, Dept. of Pharmacology (Retired), Faculty of Unani Medicine, Aligarh Muslim University, India.

Article Info:

__________________________________________

Article History:

Received 11 July 2025  

Reviewed 09 Sep 2025  

Accepted 02 Oct 2025  

Published 15 Oct 2025  

__________________________________________

Cite this article as: 

Najeeb J, Ahmad P, Bano SJahan N, Amin KMY, Therapeutic Potential of Ustukhuddus (Lavandula stoechas L.): The ‘Broom of the Brain’ in Unani Medicine and Neuropharmacology, Journal of Drug Delivery and Therapeutics. 2025; 15(10):265-271 DOI: http://dx.doi.org/10.22270/jddt.v15i10.7412     _______________________________________________

*For Correspondence:   

Najeeb Jahan, Professor and PhD Research Scholar, Dept. of Ilmul Advia (Pharmacology), National Institute of Unani Medicine, Bangalore, India.

Abstract

___________________________________________________________________________________________________________________

Objective(s): To evaluate the therapeutic significance of Ustukhuddus (Lavandula stoechas L.) in Unani medicine, focusing on its role as a brain tonic, phlegm expeller, and nervine stimulant, with particular emphasis on its ability to eliminate Saudawi (black bile) and Balghami (phlegmatic) morbid matters from the brain.

Data Sources: This study is based on a comprehensive review of classical Unani texts, including Al-Qanoon fi al-TibbKitab al-Hawi, and Al-Jamiʿ li-Mufradat al-Adwiyah, and on modern scientific databases such as PubMed, Scopus, and Google Scholar, to assess phytochemical composition and pharmacological studies on Lavandula stoechas.

Study Selection: Relevant literature was selected to highlight the traditional uses of Ustukhuddus in Unani medicine and to evaluate contemporary pharmacological evidence supporting its therapeutic actions, particularly on the central nervous system.

Summary: Unani literature documents the use of Ustukhuddus for neurological conditions, including paralysis, epilepsy, melancholia, mania, anxiety, numbness, tremors, convulsions, and chronic headaches. Modern research corroborates these uses by demonstrating the antioxidant, anti-inflammatory, neuroprotective, antidepressant, anti-spasmodic, sedative, analgesic, and anticonvulsant activities. Major phytoconstituents such as linalool, flavonoids, and phenolic compounds contribute significantly to these effects.

Conclusion: The integration of traditional knowledge with modern pharmacological evidence supports Ustukhuddus as a promising neurotherapeutic agent. Its inclusion in evidence-based Unani formulations may offer valuable potential for managing neurological disorders, warranting further clinical validation.

Keywords: Ustukhuddus; Lavandula stoechas; Unani medicine; Jarūb-i-Dimāgh; Broom of the brain; Neuroprotective.

 


 

Introduction

Ustukhuddus (Lavandula stoechas L.) belongs to the Lamiaceae family. It is commonly known as French lavender and features greyish-blue flowers with a bitter taste and a camphor-like smell.1,2 The genus Lavandula comprises approximately 39 species, numerous hybrids, and nearly 400 cultivars, with L. angustifolia, L. stoechas, L. latifolia, and L. x intermedia being the most notable.3 Greeks, Romans, and Arabs have historically used these plants for their aromatic and therapeutic qualities.4 It is a valued medicinal plant in the Unani System of Medicine (USM) and has been recognised for its neurotherapeutic properties since ancient times. Dioscorides first described it in Kitab al-Hasha’ish, where its medicinal virtues were detailed, and he named it ‘Stoechas’ after the Stoechades Islands, where it was abundantly found.2 It is traditionally cultivated in Mediterranean regions such as France, Spain, and Italy.4 Unani scholars emphasised its role in removing Saudawi (black bile) and Balghami (phlegmatic) morbid matters from the brain, earning it the nickname "Jarūb-i-Dimāgh " (broom of the brain) for its purifying effect on the central nervous system.5,6 In the Unani system, three main species are considered therapeutically important: L. stoechas (Ustukhuddus), L. angustifolia (Khuzama), and L. latifolia. Their flowers, whole plants, and essential oils have all been used therapeutically in various formulations.7 Phytochemical investigations have shown that the essential oil of L. stoechas is rich in biologically active compounds and is widely utilised in the pharmaceutical, food, cosmetic, and perfumery industries.8 About 1,500 tonnes of essential oils are extracted annually from various Lavandula species and hybrids.4 This paper aims to explore the Unani description, pharmacological effects, and therapeutic uses of Ustukhuddus, as well as to compare traditional claims with modern phytopharmacological evidence.

Geographical Distribution

L. stoechas is spread across three continents: Africa, Europe, and Asia. It grows around the Mediterranean basin, including Morocco, Algeria, Tunisia, Spain, Greece, France, Italy, and Turkey. It is also found in Saudi Arabia and Iran.3 According to Mohd et al., L. stoechas is also present in Bihar and Bengal in India.9 Furthermore, L. stoechas has been introduced and cultivated in various temperate and subtropical regions of Europe, the Americas, Asia, and Australia for medicinal, aromatic, and ornamental purposes. 10

Synonyms and Regional Names 11–16         

General Description

           Lavandula stoechas is a perennial shrub up to 90cm, grey-tomentose, leaves linear, entire, sessile with somewhat revolute margins, flowers dark purple, about 4mm, long in dense short-peduncle spikes with a terminal tuft of large purple bracts. Flowers are situated in the axils of downy, heart-shaped bracts.17

Description in Unani Literature

          Ustukhuddus (Lavandula stoechas L.) is regarded as one of the most important medicinal herbs in Unani medicine. It is an aromatic shrub, and its leaves resemble those of Sa‘tar Farsi (Zataria multiflora), although they are thinner and longer. The plant's branches are described as resembling those of Cuscuta reflexa. Its flowers are greyish-blue, found in dense terminal clusters, and possess a camphor-like fragrance with a bitter taste. 18 The herb grows in the Rabi (spring) season, prefers moist soils, and reaches up to 1.5 feet in height. The green stem is coarse and rough, measuring around half a meter, while the leaves are bluish-white, sometimes tinged with yellow or red, and covered with fine hairs on their upper surface. 19 The medicinally active parts of the plant include its leaves and flowers. 19, 20 The genus name Lavandula derives from the Latin lavare, meaning “to wash,” reflecting its historical use in ancient Greek and Roman cultures for cleansing. 21 The species name “stoechas” is derived from the Stoechades Islands, located off the coast of Marseilles, where the plant naturally grows in abundance. 22 In classical Unani texts, Ustukhuddus is often referred to as “Jarūb-i-Dimāgh” (broom of the brain) due to its ability to clear the brain of balghami (phlegmatic) impurities in Sue Mizaje Balghami (diseases caused by morbid phlegm), remove blockages, and enhance mental clarity and intellectual capacity. Its cephalic effects are well documented by Unani scholars and Greco-Arab physicians, including Galen (Jalinus), who praised its impact on the nervous system, earning it the nickname “Geyah-i-Jalinus” (Galen’s herb). Among its varieties, another lavender species, Khuzama (Lavandula officinalis), is also mentioned in Unani literature and is primarily cultivated for its volatile oil. 20  However, the new greyish variety of L. stoechas is considered the most potent for medicinal use.


 

 

 imageimage

Ustukhuddus (Lavandula stoechas L.)

 


 

Pharmacological Actions in Unani Literature

Ustukhuddus possesses Mulattif (demulcent), Muhallil (resolvent), Jali (detergent), Mufattih-i-Sudad (deobstruent), Mundij (concoctive), Munaqqi-i-Dimagh (purifier of brain), Muqawwi-i-A‘sab (nervine tonic), Munawwim (sedative), Mushil-i-Balgham (phlegmagogue), Mushil-i-Sawda (melanogogue), Muharrik-i-A‘sab (nerve stimulant), Dafi-i-Ta‘affun (antiseptic) and Muqawwi-i-Alat-i-Bawl (tonic to excretory system) properties. It is also used for its Habis (styptic), Musakkin-i-A‘sab (nerve sedative), Qabid Khafif (mild astringent), Kasir-i-reyah (carminative), Mufarrih Qalb (exhilarant), Muqawwi-i-Badan (general tonic) and Taryaq (antidote) properties.13,14,16,19,23,24 Its oil is rubefacient, antimicrobial, and used for nervous palpitations, giddiness, spasm and colic. Relieves sprains, neuralgia and rheumatism; rubbed for stimulating paralysed limbs and applied to sores, burns, scalds and varicose veins.15  

Therapeutic Uses in Unani Literature 

In USM, flowers and leaves are used to treat Amraz-i-Dimagh and A‘sab (nervous and brain diseases) such as Nazla-i-Sard (cold catarrh), Suda’ (headache), Nasiyan (amnesia), Sar‘ (epilepsy), Malankhūliyā (melancholia), Waswas sawdawi (anxiety), Junūn (mania), Jumūd (catalepsy), Fālij (paralysis/hemiplegia), Laqwa (facial paralysis), Ra’sha (chorea), Sadr (giddiness), Dawar (vertigo), Ikhtilaj (trembling), Tashannuj Imtila‘i (convulsion), Khadar (numbness), Iltihab-i-Tajawif-i-Anaf (sinusitis), etc. It relieves sprains, Waj’ al-A‘sab (neuralgia), and Waj’ al-Mafasil (rheumatism). It is also useful for Dama (asthma), Su’āl (cough), Warm-i-Jigar Sard (fatty liver), and Istisqa (ascites). Ibn Sina (Avicenna) in his famous treatise, “Advia Qalbia”, described its efficacy in removing the morbid Sawda and Balgham (black bile and phlegm) from the brain; hence, it is called “Jarub-i-Dimagh” (broom of the brain). 6,11,13,22,25   

           Temperament: 

 Haar –Yabis (Hot 1° Dry 1°) 19,22 

           Hot 1°  Dry 2°  18,19

            Hot 2°  Dry 2°  19,20 

Mazarrat (Toxicity / Adverse Effects) 18–20

According to Unani literature, Ustukhuddus is considered harmful for individuals with a hot and Safrāwī (choleric) temperament due to its inherently warm and dry nature (Har Yabis). Its overuse can worsen heat-related conditions, especially in those prone to bilious disorders such as headaches, dryness, and inflammation.

           Musleh (Correctives)18–20  

To reduce the potential adverse effects of Ustukhuddus, especially in individuals with a hot and Safrāwī temperament, Unani scholars have recommended the use of Musleh (correctives). These substances help counteract any harmful effects without diminishing the drug's therapeutic benefits.

Sikanjabeen – A vinegar-based syrup, used to balance the hot temperament and enhance palatability.

Katira (Astragalus gummifer Labill.) – A cooling and demulcent agent that counters the warm and dry nature of Ustukhuddus

Badal (Substitutes)12,19,20   

When Ustukhuddus is unavailable or contraindicated, the following Badal (substitutes) are recommended in Unani literature because of their similar therapeutic effects.

Frāsiyūn (Marrubium vulgare Linn.) – Known for its cephalic, deobstruent, and expectorant properties.

Akasbel / Aftimoon (Cuscuta reflexa) – Used as a nervine and for evacuating morbid humours, especially Sauda

Miqdār-e-Khurāk (Dosage)27 

According to the eminent Unani physician Rhazes (Al-Razi), the therapeutic dose of Ustukhuddus (Lavandula stoechas L.) ranges from 7 to 10 grams. He recommended its administration preferably with Sikanjabeen (a vinegar-based syrup), which acts as a Musleh (corrective) to moderate its hot and dry temperament and enhance its efficacy, especially in neurological and melancholic conditions. 

Phytochemical studies

Recent phytochemical investigations of Lavandula stoechas, up to 2025, confirm its rich profile of both volatile and non-volatile bioactives. Advanced GC–MS analyses of the essential oil from aerial and floral parts reveal a dominant presence of monoterpenes, such as fenchone (≈30–42%) and camphor (≈ 25–58%), alongside 1,8-cineole, linalool, and myrtenyl acetate, collectively accounting for over 50 components with notable antimicrobial and antioxidant potency.28,29  In aqueous extracts, high-performance liquid chromatography (HPLC) fingerprinting revealed significant levels of naringin (≈ 38%), syringic acid (≈26%), and cinnamic acid (≈16%), alongside rosmarinic acid, which supports antidiabetic, antioxidant, and antiglycation activities.30 Additionally, ethanol extracts exhibited elevated phenolic (≈ 148 mg/g) and flavonoid (≈ 85 mg/g) contents, with rosmarinic acid representing approximately 28.7%, which correlates with potent antioxidant and antiproliferative effects (IC₅₀: 22–94 µg/mL) against various cancer cell lines.31 These comprehensive phytochemical updates highlight L. stoechas chemotypic consistency and reinforce its emerging therapeutic relevance in metabolic, oxidative, and oncological contexts.


 

 

 

Table 1: Major Essential Oil constituents of Lavandula stoechas L. from different countries

S. No.

Country

Plant Part Used

Major compounds identified

Total Compounds

Ref

1

Algeria

Flowers,

Aerial part

Linalyl acetate (15.26%), Camphor (11.25%, 22.4%), γ-Terpinene (11.2%), Linalool (10.68%), 1,8-Cineole (10.25%),

Fenchone (31.6%), p-Cymene (6.5%), α-Pinene (1.0%)

49

 

54

32

 

33 

2

Italy

Aerial parts

Fenchone (37.0%), Camphor (27.3%), Bornyl acetate (6.2%), 1,8-Cineole (6%)

22

34 

3

Greece

Leaves

Fenchone (44.8%), 1,8-Cineole (16.7%), α-Cardinol (7.2%), Camphor (6.2%)

62

34 

4

Morocco

Aerial parts

Fenchone (30.5%), Camphor (18.2%), 1,8-Cineole (8.6%), Camphene (3.5%)

27

35 

5

Pakistan

Aerial parts

Camphor (46.24%), Borneol (6.71%), Caryophyllene (4.72%), 1,8-Cineole (3.69%)

13

36 

 

6

Portugal

Aerial parts

Fenchone (41.9%), Camphor (34.6%), Linalool (2.7%)

42

 2

7

Spain

Aerial parts

Fenchone (37%), 1,8-Cineole (17.8%), Camphor (15.6%), Linalool (7.5%)

50

37 

8

Tunisia

Aerial parts

Fenchone (34.3%), Camphor (27.4%), Lavandulyl acetate (5.6%), 1,8-Cineole (3.4%)

33

38  

9

Turkey

Flowers

Fenchone (32.03%), Camphor (14.71%), Myrtenyl acetate (11.7%), 1,8-Cineole (7.67%)

34

39  

10

India

Flowers

Camphor (52.1%), Fenchone (12.0%), 1,8-Cineole (9.7%), Bornyl acetate (6.2%), Camphene (3.3%), α-Pinene (1.1%), Terpinen-4-ol (0.6%)

25

40   

 

Table 2: Traditional Uses of Lavandula stoechas in different countries

Countries

Local names (ethnic)

Parts used

Traditional uses

Dosage form

Ref

Algeria

 

Halhal

 

Aerial part

as an analgesic for toothaches

Infusion

41 

Greece

Agrolevánta (wild lavender)

Leaves

in diabetes, menstrual pains, kidney stones, carbuncles, otitis and hypertension.

Infusion and essential oils

42 

Iran

Ossoghodus

Leaves

as an anticonvulsant, sedative antispasmodic

Infusion

43 

Morocco

Halhal

Aerial part

in rheumatism, indigestion, cystitis, and nephritis

Decoction

44 

Pakistan

Ustu khuddoos

Aerial part

in epilepsy and migraine

Decoction

45 

Portugal

Rosmaninho

Aerial part

for heartburn, seasickness, and blood circulatory disorders and for sedation

Infusion

46,47 

Spain

Cantueso, cap díase, bofarull

Flowered aerial part

as an herbal tea and for making liquor

Infusion

48 

Turkish

Karabaş

Flowering branches

expectorant, menstrual regularity, antispasmodic and carminative Infusion

Infusion

48,49

 

 

 

 

Table 3: Modern scientific reports on the Pharmacological activities of Lavandula stoechas L.

S.No

Pharmacological Activity

Extract (Dose)

Method / Model

Key Results

Ref

1

Anti-epileptogenic 

Aerial part-aqueous ethanolic extract (200–800 mg/kg)

PTZ kindling in mice, MDA, NO, and SOD assays

200 mg/kg showed a superior effect to valproate, possibly via NO suppression

50 

2

Anti-inflammatory 

Aerial part- ethanolic extract (1000, 2000 mg/kg)

Carrageenan-induced rat paw oedema

A 1000 mg/kg dose significantly reduced inflammation

51 

3

Anti-inflammatory 

Aerial part- ethanolic extract (in vitro)

LPS-stimulated macrophage model

Reduced nitrite production without cytotoxicity

34 

4

Anti-inflammatory 

Aerial part- hydroalcoholic extract (10, 25 mg/kg)

In vivo paw inflammation

Comparable to dexamethasone, reduced MMP-9, iNOS, COX-2

52 

5

Anti-inflammatory 

Aerial part- Flavonoid/tannin/mucilage extract

Carrageenan paw edema 

Reduced ROS, neutrophil apoptosis implicated

53

 

6

Antioxidant

Essential oil, ethanol extract

DPPH, phosphomolybdenum (in vitro)

Flavonoids, linalool, thymol, rutin are responsible

 2,6,51,54

7

Neuroprotective

Lavender oil (50–200 mg/kg)

Ischemia-reperfusion in mice, Longa method

Reduced protein carbonyl, MDA; ↑ SOD, CAT, GSH-Px

9

 

8

Antibacterial & Analgesic

Essential oil, aqueous, ethanolic (100–400 mg/kg)

Disk diffusion (in vitro), hot plate (in vivo)

Effective vs. Gram +ve; 400 mg/kg > morphine (60–90 min)

2

9

Cytotoxic, Scolicidal, Insecticidal

Essential oil

MTT assay, protoscolex viability, insecticidal assay

Significant cytotoxicity, 100% adulticidal effect

39

10

Anti-spasmodic & Sedative

Aqueous, methanolic extract (400, 600 mg/kg)

Irwin test, PTZ model, pentobarbital sleep time

600 mg/kg ↑ latency & sleeping time; mimics diazepam

45 

11

Antispasmodic (Jejunum)

Hydro methanolic extract (0.1–1.0 mg/mL)

Rabbit jejunum contraction

Smooth muscle relaxation; 7-methoxycoumarin active

45

 

 


 

Discussion

           The present review highlights the unique position of Ustukhuddus (L. stoechas) as a bridge between the traditional wisdom of Unani medicine and modern neuropharmacological evidence. In Unani literature, Ustukhuddus is described as “Jarūb-i-Dimāgh” (broom of the brain), owing to its ability to eliminate morbid matters of Sauda (black bile) and Balgham (phlegm) from the brain. 5,11,13,15,22,25 This traditional concept, although metaphorical, aligns with the current understanding of its role in enhancing neuroprotection, reducing oxidative stress, and modulating inflammatory mediators within the central nervous system. 9,50–52        

Phytochemical investigations have confirmed that essential oils of L. stoechas are dominated by fenchone, camphor, 1,8-cineole, and linalool, along with phenolic compounds such as rosmarinic and syringic acids. 28–30, 32–40 These constituents account for its antioxidant, anti-inflammatory, anxiolytic, neuroprotective, and anticonvulsant effects. Modern studies provide experimental validation for its traditional indications in epilepsy, melancholia, mania, paralysis, convulsions, and chronic headaches. For instance, animal studies have demonstrated anti-epileptogenic activity comparable to or superior to that of standard drugs, such as valproate, attributed to the modulation of nitric oxide and oxidative stress pathways.50 Similarly, its neuroprotective role in ischemia–reperfusion injury supports Unani claims of strengthening and cleansing the brain. 9

A noteworthy aspect is its neuroprotective and nervine tonic properties (Muqawwi-i-A‘sab), which align with current evidence of sedative, antispasmodic, and analgesic activities.45 The dual action of stimulating nerve function while exerting anxiolytic effects reflects a balanced therapeutic profile. However, its warm and dry temperament (Har Yabis) may cause adverse effects in individuals with Safrawi (choleric) constitutions, as reported in classical texts. Unani scholars recommended Sikanjabeen and Katira as Musleh (correctives) to counteract these adverse effects without reducing efficacy.18–20 A concept similar to modern pharmacovigilance, emphasising dose standardisation and formulation balance.

Comparative ethnomedicinal data from other cultures (Morocco, Greece, Portugal, Turkey, etc.) reinforce the universality of its therapeutic relevance, particularly for neurological, gastrointestinal, and inflammatory disorders. 41–48

Conclusion

Ustukhuddus shows a strong link between traditional Unani claims and modern pharmacological evidence. Its wide range of biological activities, including neuroprotective, anticonvulsant, anti-inflammatory, antioxidant, analgesic, antibacterial, cytotoxic, and sedative effects, support its use as "Jarūb-i-Dimāgh" in Unani Medicine due to its Munzij, Mushil, Mulattif, Munawwim, Jali, Mufatteh, Muqawwī-e-A‘sab properties. The overall evidence highlights its potential as a multi-targeted therapeutic agent, particularly for neurological, inflammatory, and oxidative stress-related disorders. These findings emphasise the importance of combining classical Unani knowledge of Ustukhuddus with modern biomedical research and highlight the need for further clinical and mechanistic studies to explore its therapeutic potential in contemporary integrative medicine.

Source of funding: Nil

Conflicts of interest: The authors report no conflicts of interest.

Author's contribution: The primary and corresponding author wrote the manuscript; the 2nd and 3rd authors assisted the primary author; and the last two authors served as guides.

Acknowledgement: The authors sincerely thank the Director of NIUM, Bangalore, for providing excellent reference books, a digital library, and internet facilities for literature searches in this review article. They also acknowledge all the scholars, writers, and scientists whose references have been cited in this paper.

References:

1. Anonymous. Ayurveda Pharmacopoeia of India, Part-1. Ministry of Health and Family Welfare, Govt. of India; 1986.

2. Ez zoubi Y, Bousta D, Farah A. A Phytopharmacological review of a Mediterranean plant: Lavandula stoechas L. Clinical Phytoscience. 2020; 6:9. https://doi.org/10.1186/s40816-019-0142-y

3. Upson TM, Jury SL. A revision of native Moroccan species of Lavandula L. section Pterostoechas Ging. (Lamiaceae). Taxon. 2002; 51:309-27. https://doi.org/10.2307/1554900

4. Gallotte P, Fremondière G, Gallois P, Bernier JPB, Buchwalder A, Walton A, et al. Lavandula angustifolia mill. And Lavandula x intermedia emeric ex loisel: lavender and lavandin. In: Medicinal, Aromatic and Stimulant Plants. Springer; 2020. p. 303-11. https://doi.org/10.1007/978-3-030-38792-1_6

5. Anonymous. National Formulary of Unani Medicine, Part-1. Ministry of Health and Family Welfare, Govt. of India; 1998.

6. Ghani N. Khazinul Advia. Edition 3rd. New Delhi: Idara Kitab-ul-shifa; 2011: 45, 59, 226, 227, 306, 348, 362, 479, 596, 683, 768, 1361.

7. Kalam MA, Husain Z, Haseeb A, Husain S, Shah K, Saleem B. Ustukhuddus (Lavandula stoechas L.): A boon for the management of neuropsychiatric disorders in perspective of Unani medicine-a review. Acta Scientific Pharmaceutical Sciences (ISSN: 2581-5423). 2021;5. https://doi.org/10.31080/ASPS.2021.05.0673

8. Wells R, Truong F, Adal AM, Sarker LS, Mahmoud SS. Lavandula essential oils: a current review of applications in medicinal, food, and cosmetic industries of lavender. Natural Product Communications. 2018; 13:1934578X1801301038. https://doi.org/10.1177/1934578X1801301038

9. Siddiqui M, Khalid M, Akhtar J, Siddiqui H, Ahmad U, Ahsan F, et al. Lavandula stoe-chas (Ustukhuddus): A miracle plant. J Innov Pharm Biol Sci. 2016; 3:96-102.

10. Lim TK. Edible medicinal and non-medicinal plants, Vol. 8. Springer; 2014. https://doi.org/10.1007/978-94-017-8748-2

11. Khan A. Mohit-e- Azam. Vol 1. New Delhi: CCRUM; 2012. 82, 290, 307, 500, 642, 646, 626.

12. Ibne Baitar A. Al-Jami'li-Mufradat al-Advia wa'l-Aghziyah. New Delhi (IN): Central Council for Research in Unani Medicine (CCRUM); 1985.

13. Sena I, Al Qanoon (Urdu Translation by Kantoori Gh). New Delhi: Idara Kitab-Ul-Shifa;2007. 137, 237, 272, 280, 291, 298, 327, 428, 437.

14. Halim MA. Mufradat-e-Azizi. New Delhi: CCRUM; 2009. 13, 14, 33, 47.

15. Khare CP. Indian Medicinal Plants: An Illustrated Dictionary. New Delhi: Springer (India) Pvt. Ltd; 2007. 320, 336, 365. https://doi.org/10.1007/978-0-387-70638-2 PMCid:PMC2705749

16. Kabir U. Makhzanul Mufradat. New Delhi: Idara Kitab-ul- shifa; 2007. 14, 67, 88, 108, 133, 134, 140 184, 215, 242.

17. Standardisation of single drugs of Unani medicine. Part II. New Delhi: Central Council for Research in Unani Medicine, Ministry of Health and Family Welfare, Government of India; 1987. 116, 282, 301, 306, 245.

18. Ibn Sina. Al-Qanoon fil Tib. Urdu Trans. by Kantoori GH. New Delhi: Idara Kitabus Shifa; 2007. Vol. 2, p. 277.

19. Khan Azam. Moheet-e-Azam. New Delhi: Central Council for Research in Unani Medicine; 2012. Vol. 1, pp. 30, 307.

20. Kabiruddin HM. Makhzanul Mufradat. New Delhi: Idara Kitabus Shifa; 2014. p. 67.

21. Basch E, Foppa I, Liebowitz R, Nelson J, Smith M, Sollars D, et al. Lavender (Lavandula angustifolia miller). Journal of herbal pharmacotherapy. 2004; 4:63-78. https://doi.org/10.1080/J157v04n02_07

22. IbnBaitar. Al Jami al-Mufradatul Advia wal Aghzia Vol I. New Delhi: CCRUM;1985. 54, 214.

23. Kabeeruddin M. Ilmul Advia Nafisi. New Delhi: Ejaz Publication House; 2007. 64, 174, 255.

24. Almaseehi IQ. Kitabul Umdah Fil Jarahat. 22nd ed. New Delhi: CCRUM. YNM; 234, 627.

25. Safi-Uddin. Unani Adviya Mufrrada. 10th ed. New Delhi Qaumi council barai farog urdu zaban; 1979. 32, 57, 73, 99, 106. 10th ed. New Delhi: Qaumi council barai farog urdu zaban; 1979.

26. Kabeeruddin M. Ilmul Advia Nafisi. New Delhi: Ejaz Publication House; 2007. 64, 174, 255.

27. Razi ABZ. Kitab al-Hawi fi al-Tibb [Urdu Trans: Tarjuma Kitab al-Hawi]. Vol. 2. New Delhi: CCRUM; 1999. p. 672.

28. Benali T, Lemhadri A, Harboul K, Chtibi H, Khabbach A, Jadouali SM, et al. Chemical profiling and biological properties of essential oils of lavandula stoechas L. Collected from three Moroccan sites: in vitro and in silico investigations. Plants. 2023; 12:1413. https://doi.org/10.3390/plants12061413 PMid:36987101 PMCid:PMC10057000

29. Domingues J, Delgado F, Gonçalves JC, Zuzarte M, Duarte AP. Mediterranean lavenders from section Stoechas: An undervalued source of secondary metabolites with pharmacological potential. Metabolites. 2023; 13:337. https://doi.org/10.3390/metabo13030337 PMid:36984777 PMCid:PMC10054607

30. Elrherabi A, et al. Frontiers in Pharmacology. 2024;1443311 - Aqueous extract phenolics (naringin, syringic, cinnamic acids). frontiersin.org+11frontiersin.org+11ouci.dntb.gov.ua+11 .

31. Aboalhaija N, et al. Chem Biodivers. 2025;28.7% rosmarinic acid; antiproliferative IC₅₀ 22-94 µg/mL. ouci.dntb.gov.ua+3pubmed.ncbi.nlm.nih.gov+3researchgate.net+3 

32. Barkat M, Laib I. Antioxidant activity of the essential oil from the flowers of Lavandula stoechas. J Pharmacogn Phytother. 2012; 4:96-101. https://doi.org/10.5897/JPP12.030

33. Dob T, Dahmane D, Agli M, Chelghoum C. Essential oil composition of Lavandula stoechas. from Algeria. Pharmaceutical biology. 2006; 44:60-4. https://doi.org/10.1080/13880200500496421

34. Zuzarte M, Gonçalves M, Cavaleiro C, Cruz M, Benzarti A, Marongiu B, et al. Antifungal and anti-inflammatory potential of Lavandula stoechas and Thymus herba-barona essential oils. Industrial Crops and Products. 2013; 44:97-103. https://doi.org/10.1016/j.indcrop.2012.11.002

35. Zrira S, Benjilali B. The constituents of the oils of Lavandula stoechas L. ssp. atlantica Br.-Bl. and L. stoechas ssp. stoechas from Morocco. Journal of Essential Oil Research. 2003; 15:68-9. https://doi.org/10.1080/10412905.2003.9712066

36. Taoufik F, Hamdouch A, Zine S, Chebli B, El HADEK M, IDRISSI LMH. Essential Oil Content, Chemical Composition, Antioxidant Activity and Antiviral Potential against COVID-19 of Four Aromatic and Medicinal Plants from South of Morocco. Arabian Journal of Medicinal and Aromatic Plants. 2022; 8:77-93.

37. Rathore S, Kumar R. Essential oil content and compositional variability of Lavandula species cultivated in the mid hill conditions of the western himalaya. Molecules. 2022; 27:3391. https://doi.org/10.3390/molecules27113391 PMid:35684332 PMCid:PMC9182314

38. Sriti J, Fares N, Msaada K, Zarroug Y, Boulares M, Djebbi S, et al. Phenological stage effect on phenolic composition, antioxidant, and antibacterial activity of Lavandula stoechas extract. Rivista Italiana delle Sostanze Grasse. 2022;99.

39. Giray ES, Kırıcı S, Kaya DA, Türk M, Sönmez Ö, Inan M. Comparing the effect of sub-critical water extraction with conventional extraction methods on the chemical composition of Lavandula stoechas. Talanta. 2008; 74:930-5. https://doi.org/10.1016/j.talanta.2007.07.040 PMid:18371730

40. Raina AP, Negi K. Comparative essential oil composition of Lavendula species from India. Journal of herbs, spices & medicinal plants. 2012; 18:268-73. https://doi.org/10.1080/10496475.2012.690142

41. Sarri M, Mouyet FZ, Benziane M, Cheriet A. Traditional use of medicinal plants in a city at steppic character (M'sila, Algeria). Journal of Pharmacy & Pharmacognosy Research. 2014; 2:31-5. https://doi.org/10.56499/jppres14.019_2.2.31

42. Skoula M, Abidi C, Kokkalou E. Essential oil variation of Lavandula stoechas L. ssp. stoechas growing wild in Crete (Greece). Biochemical Systematics and Ecology. 1996; 24:255-60. https://doi.org/10.1016/0305-1978(96)00023-3

43. Naghibi F, Mosadegh M, Mohammadi MS, Ghorbani A. Labiatae family in folk medicine in Iran: from ethnobotany to pharmacology. 2005;

44. El-Hilaly J, Hmammouchi M, Lyoussi B. Ethnobotanical studies and economic evaluation of medicinal plants in Taounate province (Northern Morocco). Journal of ethnopharmacology. 2003; 86:149-58. https://doi.org/10.1016/S0378-8741(03)00012-6 PMid:12738079

45. Gilani A, Aziz N, Khan M, Shaheen F, Jabeen Q, Siddiqui B, et al. Ethnopharmacological evaluation of the anticonvulsant, sedative and antispasmodic activities of Lavandula stoechas L. Journal of Ethnopharmacology. 2000; 71:161-7. https://doi.org/10.1016/S0378-8741(99)00198-1 PMid:10904159

46. Camejo-Rodrigues J, Ascensao L, Bonet MÀ, Valles J. An ethnobotanical study of medicinal and aromatic plants in the Natural Park of "Serra de São Mamede" (Portugal). Journal of Ethnopharmacology. 2003; 89:199-209. https://doi.org/10.1016/S0378-8741(03)00270-8 PMid:14611883

47. Novais MH, Santos I, Mendes S, Pinto-Gomes C. Studies on pharmaceutical ethnobotany in Arrábida natural park (Portugal). Journal of ethnopharmacology. 2004; 93:183-95. https://doi.org/10.1016/j.jep.2004.02.015 PMid:15234752

48. Tardío J, Pardo-de-Santayana M, Morales R. Ethnobotanical review of wild edible plants in Spain. Botanical journal of the Linnean society. 2006; 152:27-71. https://doi.org/10.1111/j.1095-8339.2006.00549.x

49. Polat R, Satıl F. An ethnobotanical survey of medicinal plants in Edremit Gulf (Balıkesir-Turkey). Journal of Ethnopharmacology. 2012; 139:626-41. https://doi.org/10.1016/j.jep.2011.12.004 PMid:22193175

50. Anti-epileptogenic - Thesis Paper [unpublished]; cited in: Kalam MA. Ustukhuddus (Lavandula stoechas L.): A Boon... Acta Sci Pharm Sci. 2021;5(3):02-09. https://doi.org/10.31080/ASPS.2021.05.0673

51. Yassine EZ, Dalila B, Latifa EM, Smahan B, Lebtar S, Sanae A, et al. Phytochemical screening, anti-inflammatory activity and acute toxicity of hydro-ethanolic, flavonoid, tannin and mucilage extracts of Lavandula stoechas L. from Morocco. Int J Pharm Phytochem Res. 2016; 8:31-7.

52. Algieri F, Rodriguez-Nogales A, Vezza T, Garrido-Mesa J, Garrido-Mesa N, Utrilla MP, et al. Anti-inflammatory activity of hydroalcoholic extracts of Lavandula dentata L. and Lavandula stoechas L. Journal of ethnopharmacology. 2016; 190:142-58. https://doi.org/10.1016/j.jep.2016.05.063 PMid:27269390

53. Messaoud C, Chograni H, Boussaid M. Chemical composition and antioxidant activities of essential oils and methanol extracts of three wild Lavandula L. species. Natural product research. 2012; 26:1976-84. https://doi.org/10.1080/14786419.2011.635343 PMid:22117129

54. Apak R, Güçlü K, Özyürek M, Karademir SE. Novel total antioxidant capacity index for dietary polyphenols and vitamins C and E, using their cupric ion reducing capability in the presence of neocuproine: CUPRAC method. Journal of agricultural and food chemistry. 2004; 52:7970-81. https://doi.org/10.1021/jf048741x PMid:15612784